Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
  • Produktbild: Ciclosporin in Autoimmune Diseases
  • Produktbild: Ciclosporin in Autoimmune Diseases

Ciclosporin in Autoimmune Diseases 1st International Symposium, Basle, March 18–20, 1985

Fr. 137.00

inkl. gesetzl. MwSt., Versandkostenfrei

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

06.12.2011

Herausgeber

Rosemarie Schindler

Verlag

Springer Berlin

Seitenzahl

386

Maße (L/B/H)

24.4/17/2.2 cm

Gewicht

693 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-3-642-70609-7

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

06.12.2011

Herausgeber

Rosemarie Schindler

Verlag

Springer Berlin

Seitenzahl

386

Maße (L/B/H)

24.4/17/2.2 cm

Gewicht

693 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-3-642-70609-7

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Ciclosporin in Autoimmune Diseases
  • Produktbild: Ciclosporin in Autoimmune Diseases
  • Preface to CyA Proceedings.- 1. Autoimmunity and Ciclosporin (CyA).- Prevailing Theories in Autoimmune Disorders.- Genetic Role in Autoimmunity.- The Mechanism of Action of Ciclosporin: A Continuing Puzzle.- Contrasting Effects of Ciclosporin on Humoral and Cell-mediated Immunity in Patients with Autoimmune Diseases.- Pharmacokinetics and Interactions of Ciclosporin.- Side Effects and Safety of Sandimmun® in Long-term Treatment of Transplant Patients.- Ciclosporin-associated Nephropathy.- Ciclosporin in Autoimmune Diseases — Side Effects (with Emphasis on Renal Dysfunction) and Recommendations for Use.- Clinical Effects and Renal Side Effects in Patients with Autoimmune Diseases Treated with Ciclosporin (CyA).- 2. Multiple Sclerosis — Myasthenia Gravis — Polymyositis.- The Use of Ciclosporin (CyA) in Multiple Sclerosis — Trial Design and Tolerance.- The Effect of Ciclosporin versus Azathioprine on the Course of Multiple Sclerosis; Design of a Long-term Follow-up Study and Side Effects.- Ciclosporin in the Treatment of Myasthenia Gravis: Preliminary Results from a Pilot Study.- Ciclosporin in Myasthenia Gravis.- Ciclosporin in the Treatment of Polymyositis/Idiopathic Cardiomyopathy.- 3. Diabetes Mellitus Type I.- Type I Diabetes Mellitus: Rationale for Immune Intervention.- Effects of Ciclosporin on Insulin Secretion in Recent Onset Type I Diabetes Mellitus.- Ciclosporin in Insulin-dependent Diabetes Mellitus: Design of Controlled Studies.- 4. Uveitis and Behçet’s Disease.- Effectiveness of Ciclosporin on Sight-threatening Endogenous Uveitis.- Treatment of Noninfectious Inflammatory Disorders of the Eye with Ciclosporin.- Ciclosporin (CyA) in the Treatment of Retinal Vasculitis.- Ciclosporin Treatment of Autoimmune Inflammatory Disorders of the Eye.- Treatment of Ocular Involvement in Behçet’s Disease with Ciclosporin A (Preliminary Report).- Preliminary Results of a Randomized Prospective Study on Treatment of Posterior Uveitis with Ciclosporin or Prednisolone.- Ciclosporin in Idiopathic Posterior Uveitis; Interim Report of a Randomized Double-masked Study.- Ciclosporin (CyA) Versus Conventional Therapy in Behçet’s Disease. Preliminary Observations of a Masked Study.- A Double-masked Study of Ciclosporin Treatment in Behçet’s Disease.- 5. Primary Biliary Cirrhosis — Crohn’s Disease.- Primary Biliary Cirrhosis.- Effect of Ciclosporin (CyA) on Suppressor Cell Function in Patients with Primary Biliary Cirrhosis.- Treatment of Primary Biliary Cirrhosis with Ciclosporin (CyA), Pilot Study.- Ciclosporin Therapy in Primary Biliary Cirrhosis (PBC): A Pilot Study in 10 Patients.- Ciclosporin (CyA) in Primary Biliary Cirrhosis (PBC). A Multicentre, Double-blind, Placebo-controlled Long-term Therapeutic Study. The Study Design.- Ciclosporin for Crohn’s Disease.- Controlled Study of Ciclosporin versus Corticosteroids in Acute Crohn’s Disease: Methodology and Early Findings.- 6. Sarcoidosis — Dermatology.- Ciclosporin (CyA) in the Treatment of Pulmonary Sarcoidosis.- Ciclosporin (CyA) as an Alternative to Steroids in the Treatment of Sarcoidosis and Cryptogenic Interstitial Lung Diseases.- Ciclosporin in the Treatment of Progressive Systemic Sclerosis.- Ciclosporin Inhibits the Effector Function of the T Effector Cell of Delayed Type Hypersensitivity.- Treatment of Pemphigus with Ciclosporin.- Treatment of Bullous Dermatoses with Ciclosporin (CyA).- Ciclosporin (CyA) in Pemphigus and Bullous Pemphigoid.- 7. Endocrine Ophthalmopathy.- Endocrine Ophthalmopathy.- Ciclosporin in the Treatment of Graves’ Ophthalmopathy.- Treatment of Graves’ Ophthalmopathy with Ciclosporin.- A Pilot Study of Ciclosporin in Endocrine Ophthalmopathy.- Ciclosporin Treatment in Severe Graves’ Ophthalmopathy.- 8. Hematology.- Ciclosporin (CyA) as Primary Treatment for Severe Acute Aplastic Anaemia.- Ciclosporin for Therapy of Severe Aplastic Anemia (SAA) and Pure Red Cell Aplasia (PRCA).- Experience with Ciclosporin (CyA) in the Management of Pure Red-Cell Aplasia (PRCA) and Aplastic Anemia (AA).- Ciclosporin in Idiopathic Thrombocytopenic Purpura and Other “Auto-Immune” Cytopenias.- Ciclosporin (CyA) and Intravenous Immunoglobulin (i.V. IgG) in Chronic Immune Thrombocytopenic Purpura (ITP) in Childhood: A Clinical and Immunological Study (Progress Report).- Ciclosporin (CyA) in the Treatment of Autoimmune Blood Disorders.- 9. Rheumatoid Arthritis.- Rheumatoid Arthritis.- Ciclosporin in Rheumatoid Arthritis. Open Trials with Different Dosages.- A Pilot Study of CyA in Patients with Rheumatoid Arthritis (RA).- Low Dose Ciclosporin A and Prednisone — a Step in the Direction of Selective Immunosuppression in Rheumatoid Arthritis Refractory to Treatment (6-Month Follow-Up).- Ciclosporin in Rheumatoid Arthritis — Preliminary Results.- Ciclosporin Treatment in Rheumatoid Arthritis: A Preliminary Report of a Multicentre Placebo-Controlled Double-Blind Study.- Ciclosporin versus Azathioprine in Rheumatoid Arthritis.- Preliminary Observations from a Comparison of Ciclosporin and Azathioprine in Rheumatoid Arthritis.- 10. Glomerulonephritis and Systemic Lupus Erythematosus.- Ciclosporin in Glomerulonephritis — A Pilot Study.- Use of Ciclosporin in Idiopathic Corticoresistant or Cortico-dependent Nephrotic Syndrome (Minimal Change Glomerulopathy and Focal-Segmental Hyalinosis).- Ciclosporin (CyA) in Steroid-insensitive Nephrotic Syndrome in Durban, South Africa.- Ciclosporin Treatment of Idiopathic Nephrotic Syndrome in Children (Minimal Change Disease and Focal Segmental Glomerulosclerosis).- What can NZB/W Mice Teach us about the Treatment of SLE with Ciclosporin?.- Combined Ciclosporin-Steroid Treatment of Systemic Lupus Erythematosus.- Ciclosporin (CyA) and Therapeutic Plasma Exchange in Steroid Resistant SLE.- Possible Beneficial Effect of Ciclosporin in Some Cases of Severe Systemic Lupus Erythematosus.- Open Therapeutic Trial of Ciclosporin in Systemic Lupus Erythematosus. Preliminary Results in 4 Patients.- The Effects of Ciclosporin in Twelve Patients with Severe Systemic Lupus.- Ciclosporin and Autoimmune Disease — an Overview.- Concluding Impressions.